Literature DB >> 3155764

Antigen presentation in the rat. II. An Ia+ radiosensitive T cell can present antigen to primed Ia- T cells.

M L Sopori, D A Cohen, S Cherian, R S Perrone, A M Kaplan.   

Abstract

We demonstrated previously the presence of an Ia+ (OX-6+) antigen-presenting cell within the rat T cell fraction that is capable of presenting antigen to antigen-primed OX-6-T cells. This antigen-presenting cell (T-APC) reacted with the monoclonal antibodies W3/25 and W3/13, which is known to react mainly with rat T cells. Further characterization of the T-APC indicated that the cell also reacted with the monoclonal antibody OX-19, which is highly specific for rat T cells. Moreover, the antigen-presenting function of the T-APC was sensitive to treatment with mitomycin C or gamma-irradiation (2000 rad). Under similar conditions, antigen presentation by partially purified dendritic cells or macrophages was totally resistant to these treatments. The antigen-presenting activity of gamma-irradiated T-APC was not reconstituted by the addition of the lymphokines IL 1, IL 2, or Con A supernatants. Although unirradiated T-APC were able to stimulate an MLR response, this function was also sensitive to gamma-irradiation, whereas the MLR-stimulating ability of macrophages and dendritic cells was resistant to gamma-irradiation. These data indicate that Ia+ T cells from the rat are capable of presenting antigen to antigen-primed T lymphocytes and that, in contrast to antigen presentation by macrophages and dendritic cells, the function of T-APC is gamma-radiation sensitive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Activated rat T cells synthesize and express functional major histocompatibility class II antigens.

Authors:  C P Broeren; M H Wauben; M A Lucassen; M Van Meurs; P J Van Kooten; C J Boog; E Claassen; W Van Eden
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

3.  Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.

Authors:  Steven E Finkelstein; Cristina Iclozan; Marilyn M Bui; Matthew J Cotter; Rupal Ramakrishnan; Jamil Ahmed; David R Noyes; David Cheong; Ricardo J Gonzalez; Randy V Heysek; Claudia Berman; Brianna C Lenox; William Janssen; Jonathan S Zager; Vernon K Sondak; G Douglas Letson; Scott J Antonia; Dmitry I Gabrilovich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-11       Impact factor: 7.038

4.  Interleukin-10 and antigen-presenting cells actively suppress Th1 cells in BALB/c mice infected with the filarial parasite Brugia pahangi.

Authors:  J Osborne; E Devaney
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions.

Authors:  J Picus; K Holley; W R Aldrich; J D Griffin; N L Letvin
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

6.  Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type.

Authors:  H Secrist; R H DeKruyff; D T Umetsu
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.